NFKB1 and COVID-19: Unregulated ROS production may activate NF-κB and promote excessive cytokine release [107] as well as specifically contributing to the pathogenesis of COVID-19-related acute respiratory distress syndrome (ARDS), by increasing the tendency for thrombotic micronangiopathy [108].